Literature DB >> 11338231

Kawasaki disease--atypical presentation.

D Mishra1, R Uttam, P Khilnani.   

Abstract

Kawasaki disease, an acute systemic vasculitis of unknown etiology, is the leading cause of acquired heart disease in children in many parts of the world. It predominantly affects children under 5 years of age and is diagnosed clinically by the presence of characteristic clinical signs. Atypical patients, often younger than 1 year of age, manifest few early signs, usually have an incorrect admitting diagnosis and suffer from high morbidity and mortality. We report the presentation, clinical course and follow-up of a 3-month-old infant with atypical Kawasaki disease.

Entities:  

Mesh:

Year:  2001        PMID: 11338231     DOI: 10.1007/BF02723210

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

Review 1.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Pediatr Clin North Am       Date:  1999-04       Impact factor: 3.278

Review 2.  Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988.

Authors: 
Journal:  Pediatr Infect Dis J       Date:  1989-10       Impact factor: 2.129

Review 3.  Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues.

Authors:  M Levy; G Koren
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

4.  Kawasaki disease at Chandigarh.

Authors:  S Singh; L Kumar; A Trehan; R K Marwaha
Journal:  Indian Pediatr       Date:  1997-09       Impact factor: 1.411

5.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 6.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

Review 7.  Epidemiology, etiology, and management of Kawasaki disease: state of the art.

Authors:  K B Laupland; H Dele Davies
Journal:  Pediatr Cardiol       Date:  1999 May-Jun       Impact factor: 1.655

8.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

9.  Clinical aspects of 100 patients with Kawasaki disease.

Authors:  E J Tizard; A Suzuki; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

10.  Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  A S Dajani; K A Taubert; M Takahashi; F Z Bierman; M D Freed; P Ferrieri; M Gerber; S T Shulman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.